HCA Healthcare Inc

Chart & Performance

D1W1MN

P/E

14.67

P/S

1.18

EPS

20.70

Div Yield, %

0.86%

Shrs. gr., 5y

-4.90%

Rev. gr., 5y

6.84%

Revenues

64.97b

+7.86%

Net income

5.24b

-7.11%

CFO

9.43b

+10.67%

Dividend

Sep 16, 20240.66 USD/sh

Earnings

Jan 28, 2025

Profile

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

URL

https://hcahealthcare.com/

IPO date

Dec 28, 2010

Employees

207,000

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12	2014‑12
Income
Revenues	64,968,000 7.86%	60,233,000 2.52%	58,752,000 14.01%
Cost of revenue	84,828,000	37,056,000	36,260,000
Unusual Expense (Income)
NOPBT	(19,860,000)	23,177,000	22,492,000
NOPBT Margin		38.48%	38.28%
Operating Taxes	1,615,000	1,746,000	2,112,000
Tax Rate		7.53%	9.39%
NOPAT	(21,475,000)	21,431,000	20,380,000
Net income	5,242,000 -7.11%	5,643,000 -18.88%	6,956,000 85.30%
Dividends	(661,000)	(653,000)	(624,000)
Dividend yield	0.88%	0.92%	0.74%
Proceeds from repurchase of equity	(3,811,000)	(7,000,000)	(8,215,000)
BB yield	5.09%	9.90%	9.73%
Debt
Debt current	2,787,000	370,000	237,000
Long-term debt	41,338,000	41,218,000	37,852,000
Deferred revenue
Other long-term liabilities	3,424,000	3,143,000	3,574,000
Net debt	41,836,000	39,476,000	35,752,000
Cash flow
Cash from operating activities	9,431,000	8,522,000	8,959,000
CAPEX	(4,744,000)	(4,395,000)	(3,577,000)
Cash from investing activities	(5,317,000)	(3,389,000)	(2,643,000)
Cash from financing activities	(4,094,000)	(5,656,000)	(6,655,000)
FCF	(24,973,000)	19,510,000	18,726,000
Balance
Cash	1,022,000	908,000	1,451,000
Long term investments	1,267,000	1,204,000	886,000
Excess cash
Stockholders' equity	1,060,000	(73,000)	1,489,000
Invested Capital	46,343,000	42,608,000	41,036,000
ROIC		51.24%	51.17%
ROCE		54.49%	54.81%
EV
Common stock shares outstanding	276,412	294,666	328,752
Price	270.68 12.80%	239.96 -6.60%	256.92 56.22%
Market cap	74,819,200 5.81%	70,708,053 -16.29%	84,462,964 49.47%
EV	119,489,200	112,878,053	122,636,964
EBITDA	(16,783,000)	26,146,000	25,345,000
EV/EBITDA		4.32	4.84
Interest	1,938,000	1,741,000	1,566,000
Interest/NOPBT		7.51%	6.96%